Developing Selection Criteria for Prostate-sparing Cystectomy: A Review of Cystoprostatectomy Specimens

Urology

Volumn 75, Issue 5, 2010, Pages 1116-1120

  Richards, Kyle A ^a   Parks, Graham E ^a   Badlani, Gopal H ^a   Kader, A Karim ^a   Hemal, Ashok K ^a   Pettus, Joseph A ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT CONTRAINDICATION; TUMOR LOCALIZATION;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 77951667812     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.09.081     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics 2006. CA Cancer J Clin 56 (2006) 106-130
2. Dinney C.P. Therapy of invasive bladder cancer. Urology 67 (2006) 56-59
3. Stein J.P., and Skinner D.G. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol 24 (2006) 296-304
4. Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery-only series in the neobladder era. J Urol 176 (2006) 486-492
5. Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16 (1998) 3576-3583
6. Tester W., Caplan R., Heaney J., et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 14 (1996) 119-126
7. Kachnic L.A., Kaufman D.S., Heney N.M., et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15 (1997) 1022-1029
8. Shabsigh A., Korets R., Vora K.C., et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55 (2009) 164-176
9. Hara I., Miyake H., Hara S., et al. Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. BJU Int 89 (2002) 10-13
10. Dutta S.C., Chang S.C., Coffey C.S., et al. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol 168 (2002) 164-167
11. Hart S., Skinner E.C., Meyerowitz B.E., et al. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral Kock pouch. J Urol 162 (1999) 77-81
12. Zippe C.D., Raina R., Massanyi E.Z., et al. Sexual function after male radical cystectomy in a sexually active population. Urology 64 (2004) 682-685
13. Hautmann R.E., de Petriconi R., Gottfried H.W., et al. The ileal neobladder complications and functional results in 363 patients after 11 years of follow-up. J Urol 161 (1999) 422-428
14. Schoenberg M.P., Walsh P.C., Breazeale D.R., et al. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 155 (1996) 490-494
15. Vallancian G., El Fettouh H.A., Cathelineau X., et al. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 168 (2002) 2413-2417
16. Rozet F., Lesur G., Cathelineau X., et al. Oncological evaluation of prostate sparing cystectomy: the Montsouris long-term results. J Urol 179 (2008) 2170-2175
17. Simone G., Papalla R., Leonardo C., et al. Prostatic capsule and seminal vesicle-sparing cystectomy: improved functional results, inferior oncologic outcome. Urology 72 (2008) 162-166
18. Kefer J.C., and Campbell S.C. Current status of prostate sparing cystectomy. Urol Oncol 28 (2008) 486-493
19. Pettus J.A., Al-Ahmadie H., Barocas D.A., et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 53 (2008) 370-375
20. Revelo M.P., Cookson M.S., Chang S.S., et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171 (2004) 646-649
21. Hong Y.M., Lai F.C., Chon C.H., et al. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol 22 (2004) 7-10
22. Esrig D., Freeman J.A., Elmajian D.A., et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stroma invasion. J Urol 156 (1996) 1071-1076
23. Epstein J.I., Chan D.W., Sokoll L.J., et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 160 (1998) 2407-2411
24. Meng M.V., Franks J.H., Presti Jr. J.C., et al. The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol 21 (2003) 361-365
25. Wood Jr. D.P., Montie J.E., Pontes J.E., et al. Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study. J Urol 142 (1989) 83-85
26. Donat S.M., Wei D.C., McGuire M.S., et al. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol 165 (2001) 1580-1584
27. Donat S.M., Genega E.M., Herr H.W., et al. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 165 (2001) 1117-1120
28. Nixon R.G., Chang S.S., Lafleur B.J., et al. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 167 (2002) 502-505
29. Kefer J.C., Voelzke B.B., Flanigan R.C., et al. Risk assessment for occult malignancy in the prostate before radical cystectomy. Urology 66 (2005) 1251-1255
30. Clark P.E., Stein J.P., Groshen S.G., et al. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. J Urol 172 (2004) 1342-1347